Alternatively, the detected immunoreactivity might simply be a read-out elicited by the aberrant surface expression of the immature non-functional ADAM10 isoform, and the explanation for the observed favorable clinical outcome can be related to an alteration of the ADAM10 functions that are associated with tumor progression and invasion [31–37]. Here, ADAM10 is linked to neoplasm.